Vol. 23 No. 1 (2019)
NEUROSURGERY

Prognostic significance of microRNAs in survival of patients with supratentorial gliomas

PDF (Русский)
  • E. Stupak,
  • S. Titov,
  • Yu. Versyaskina,
  • L. Akhmerova,
  • I. Zhimulyov,
  • V. Stupak,
  • S. Rabinovich,
  • A. Simonovich,
  • D. Dolzhenko
E. Stupak
Novosibirsk Research Institute of Traumotology and Ortopaedics of the Ministry of Health of Russian Federation, Novosibirsk, Russian Federation
Bio
S. Titov
Institute of Molecular and Cell Biology of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russian Federation; Vector-Best, Novosibirsk, Russian Federation
Yu. Versyaskina
Institute of Molecular and Cell Biology of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russian Federation; Vector-Best, Novosibirsk, Russian Federation
L. Akhmerova
Institute of Molecular and Cell Biology of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russian Federation
I. Zhimulyov
Institute of Molecular and Cell Biology of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russian Federation
V. Stupak
Novosibirsk Research Institute of Traumotology and Ortopaedics of the Ministry of Health of Russian Federation, Novosibirsk, Russian Federation
S. Rabinovich
Novosibirsk Research Institute of Traumotology and Ortopaedics of the Ministry of Health of Russian Federation, Novosibirsk, Russian Federation; Novosibirsk State Medical University of the Ministry of Health of Russian Federation, Novosibirsk, Russian Federation
A. Simonovich
Novosibirsk Research Institute of Traumotology and Ortopaedics of the Ministry of Health of Russian Federation, Novosibirsk, Russian Federation
D. Dolzhenko
Regional Clinical Hospital, Barnaul, Russian Federation
DOI: https://doi.org/10.21688/1681-3472-2019-1-61-70

Published 2019-03-09

Keywords

  • brain glioma,
  • microRNA,
  • molecular genetics,
  • survival predictor

How to Cite

Stupak, E., Titov, S., Versyaskina, Y., Akhmerova, L., Zhimulyov, I., Stupak, V., Rabinovich, S., Simonovich, A., & Dolzhenko, D. (2019). Prognostic significance of microRNAs in survival of patients with supratentorial gliomas. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 23(1), 61–70. https://doi.org/10.21688/1681-3472-2019-1-61-70

Copyright (c) 2019 Stupak E. V., Titov S. E., Versyaskina Yu. A., Akhmerova L. G., Zhimulyov I. E., Stupak V. V., Rabinovich S. S., Simonovich A. E., Dolzhenko D. A.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Aim. To identify novel microRNA markers as survival predictors in patients with supratentorial gliomas.
Methods. This study involved the analysis of tumour and normal brain tissue biopsy samples obtained from patients undergoing combination treatment for supratentorial gliomas of different World Health Organization (WHO) grades. Real-time polymerase chain reaction was used to determine the expression profiles of ten microRNAs, following comparison with clinical treatment results: tumour morphology, WHO grade, patient age, Karnofsky scale, treatment type, postsurgical survival rate and histological diagnosis. The mean age of surgically treated patients [62 (57.9%) males and 45 (42.1%) females] was 48.8 ± 14 years. There were 17 (16%), 30 (28%) and 60 (56%) patients with grade II, III and IV (glioblastoma) gliomas, respectively. Statistical analysis was performed using Statistica version 10.0 and GraphPad Prism version 5.
Results. Four microRNAs (miRNA-31, miRNA-21, miRNA-223 and miRNA-221) were strongly correlated with worse survival, when over-expressed, indicating their potential utility as survival predictors in glioma patients. Overexpression of these microRNAs in glioma tissue, lack of adjuvant therapy such as chemotherapy or radiotherapy and age > 48 years were identified as factors for worse prognosis.

Received 14 May 2019. Revised 21 June 2019. Accepted 25 June 2019.

Funding: This work was supported by the program of fundamental scientific research on the topic 0310-2019-0003.

Conflict of interest: The authors declare no conflict of interest.

PDF (Русский)

References

  1. Зозуля Ю.А., Васильева И.Г., Главацкий А.Я. Глиомы головного мозга. Киев: УИПК «ЕксОб», 2007. 636 с. [Zozulya Yu.A., Vasilyeva I.G., Glavatsky A.Ya. Brain gliomas. Kiev, UIPK «ExOb», 2007. 636 p. (In Russ.)].
  2. Олюшин В.Е., Филатов М.В., Улитин А.Ю., Бажанов С.П. Специфическая противоопухолевая иммунотерапия на основе дендритных клеток в комплексном лечении больных злокачественными церебральными глиомами. СПб.: Знакъ, 2012. 212 с. [Olyushin V.E., Filatov M.V., Ulitin A.Yu., Bazhanov S.P. Specific antitumor immunotherapy based on dendritic cells in the complex treatment of patients with malignant cerebral gliomas. Saint Petersburg, Znak, 2012. 212 p. (In Russ.)].
  3. Keles G.E., Lamborn K., Berger M.S. Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. Neurosurgery. 2001;95:735-745. PMID: 11702861. http://doi.org/10.3171/jns.2001.95.5.0735
  4. Bhattacharjee A.K., Nagashima Т., Kondoh Т., Tamaki N. Quantification of early blood-brain barrier disruption by in situ brain perfusion technique. Brain Res Protoc. 2001;(2):126-131. PMID: 11673094.
  5. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., Jouvet A., Scheithauer B.W., Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97-109. PMCID: PMC1929165, PMID: 17618441. http://doi.org/10.1007/s00401-007-0243-4
  6. Mittler M.A., Walters B.C., Stopa E.G. Observer reliability in histological grading of astrocytoma stereotactic biopsies. J Neurosurg. 1996;85(6):1091-1094. PMID: 8929500. http://doi.org/10.3171/jns.1996.85.6.1091
  7. Babu R., Komisarow J.M., Agarwal V.J., Rahimpour S., Iyer A., Britt D., Karikari I.O., Grossi P.M., Thomas S., Friedman A.H., Adamson C. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival. J Neurosurg. 2016;124(4):998-1007. PMID: 26452121. http://doi.org/10.3171/2015.4.JNS142200
  8. Stupp R., Hegi M.E., Mason W.P., Van den Bent M.J., Taphoorn M.J., Janzer R.C., Ludwin S.K., Allgeier A., Fisher B., Belanger K., Hau P., Brandes A.A., Gijtenbeek J., Marosi C., Vecht C.J., Mokhtari K., Wesseling P., Villa S., Eisenhauer E., Gorlia T., Weller M., Lacombe D., Cairncross J.G., Mirimanoff R.O. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459-466. PMID: 19269895. http://doi.org/10.1016/S1470-2045(09)70025-7
  9. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K. (ed.) WHO Classification of tumours of the central nervous system. Revised 4th ed. Lyon, IARC, 2016. 408 p.
  10. Ambros V. The functions of animal microRNAs. Nature. 2004;431(700):350-355. PMID: 15372042. http://doi.org/10.1038/nature02871
  11. Rodriguez A., Griffiths-Jones S., Ashurst J.L., Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res. 2004;14(10A):1902-1910. PMID: 15364901, PMCID: PMC524413. http://doi.org/10.1101/gr.2722704
  12. Andorfer C.A., Necela B.M., Thompson E.A., Perez E.A. MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer. Trends Mol Med. 2011;17(6):313-319. PMID: 21376668. http://doi.org/10.1016/j.molmed.2011.01.006
  13. Sasahira T., Kurihara M., Bhawal U.K., Ueda N., Shimomoto T., Yamamoto K., Kirita T., Kuniyasu H. Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer. Br J Cancer. 2012;107(4):700-706. PMCID: PMC3419968, PMID: 22836510. http://doi.org/10.1038/bjc.2012.330
  14. Chen C., Ridzon D.A., Broomer A.J., Zhou Z., Lee D.H., Nguyen J.T., Barbisin M., Xu N.L., Mahuvakar V.R., Andersen M.R., Lao K.Q., Livak K.J., Guegler K.J. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Research. 2005;33(20):e179. PMID: 16314309, PMCID: PMC1292995. http://doi.org/10.1093/nar/gni178
  15. Conti A., Aguennouz M., La Torre D., Tomasello C., Cardali S., Angileri F.F., Maio F., Cama A., Germanò A., Vita G., Tomasello F. miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors. J Neurooncol. 2009;93(3):325-332. PMID: 19159078. http://doi.org/10.1007/s11060-009-9797-4
  16. Ступак Е.В., Титов С.Е., Веряскина Ю.А., Ахмерова Л.Г., Ступак В.В., Рабинович С.С., Долженко Д.А., Жимулёв И.Ф. Поиск новых микроРНК-маркеров для дифференциальной диагностики глиом головного мозга различной степени злокачественности. Сибирский научный медицинский журнал. 2018;38(6):85-93. http://doi.org/10.15372/SSMJ20180613 [Stupak E.V., Titov S.E., Veryaskina Yu.A., Akhmerova L.G., Stupak V.V., Rabinovich S.S., Dolzhenko D.A., Zhimulev I.F. Searching new miRNA markers for the differential diagnosis of brain gliomas of malignancy various degrees. Siberian Scientific Medical Journal. 2018;38(6):85-93. (In Russ.) http://doi.org/10.15372/SSMJ20180613].
  17. Visani M., de Biase D., Marucci G., Taccioli C., Baruzzi A., Pession A. Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference. PLoS One. 2013;8(1):e55314. https://doi.org/10.1371/journal.pone.0055314
  18. Ступак Е.В., Веряскина Ю.А., Титов С.Е., Ахмерова Л.Г., Ступак В.В., Мишинов С.В., Копорушко Н.А., Петрова Ю.В., Пустаханов В.В., Иванов М.К., Жумулев И.Ф., Колесников Н.Н. Значение профиля миРНК в диагностике злокачественных глиом головного мозга. Российский нейрохирургический журнал. 2016;8(2):54-58. Режим доступа: http://congress-ph.ru/common/htdocs/upload/fm/magazin-polenov/RN_journal_2016_2.pdf [Stupak E.V., Versyaskina Yu.A., Titov S.E., Akhmerova L.G., Stupak V.V., Mishinov S.V., Koporushko N.А., Petrova Yu.V. Pustokhanov V.V., Ivanov M.K., Zhumulev I.F., Kolesnikov N.N. MicroRNA profile at diagnostics of brain malignant gliomas. Russian Neurosurgical Journal. 2016;8(2):54-58. (In Russ.) Available from: http://congress-ph.ru/common/htdocs/upload/fm/magazin-polenov/RN_journal_2016_2.pdf].
  19. Wu L., Li G., Feng D., Qin H., Gong L., Zhang J., Zhang Z. MicroRNA-21 expression is associated with overall survival in patients with glioma. Diagn Pathol. 2013;8:200. PMID: 24326156, PMCID: PMC3933412. https://doi.org/10.1186/1746-1596-8-200
  20. Hao J., Zhang C., Zhang A., Wang K., Jia Z., Wang G., Han L., Kang C., Pu P. miR-221/222 is the regulator of Cx43 expression in human glioblastoma cells. Oncol Rep. 2012;27(5):1504-1510. PMID: 22294051. https://doi.org/10.3892/or.2012.1652
  21. Galardi S., Mercatelli N., Farace M.G., Ciafre S.A. NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma. Nucleic Acids Res. 2011;39(9):3892-3902. PMID: 21245048, PMCID: PMC3089483. https://doi.org/10.1093/nar/gkr006
  22. Quintavalle C., Garofalo M., Zanca C., Romano G., Iaboni M., del Basso De Caro M., Martinez-Montero J.C., Incoronato M., Nuovo G., Croce C.M., Condorelli G. miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPmu. Oncogene. 2012;31(7):858-868. PMCID: PMC4299860, PMID: 21743492. https://doi.org/10.1038/onc.2011.280
  23. Rajbhandari R., McFarland B.C., Patel A., Gerigk M., Gray G.K., Fehling S.C., Bredel M., Berbari N.F., Kim H., Marks M.P., Meares G.P., Sinha T., Chuang J., Benveniste E.N., Nozell S.E. Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastoma. Oncotarget. 2015;19(6):17805-17816. PMCID: PMC4627347, PMID: 26164206. https://doi.org/10.18632/oncotarget.4596
  24. Huang B.S., Luo Q.Z., Han Y., Li X.B., Cao L.J., Wu L.X. MicroRNA-223 promotes the growth and invasion of glioblastoma cells by targeting tumor suppressor PAX6. Oncol Rep. 2013;30(5):2263-2269. PMID: 23970099. https://doi.org/10.3892/or.2013.2683
  25. Ding Q., Shen L., Nie X., Lu B., Pan X., Su Z., Yan A., Yan R., Zhou Y., Li L., Xu J. MiR-223-3p overexpression inhibits cell proliferation and migration by regulating inflammation-associated cytokines in glioblastomas. Pathol Res Pract. 2018;214(9):1330-1339. https://doi.org/10.1148/radiol.2018172131
  26. Клинические рекомендации по диагностике и лечению больных с первичными опухолями головного мозга. М.: Ассоциация онкологов России, 2014. Режим доступа: http://www.oncology.ru/association/clinical-guidelines/2014/32.pdf [Clinical guidelines for the diagnosis and treatment of patients with primary brain tumors. Moscow, Association of Oncologists of Russia, 2014. (In Russ.) Available from: http://www.oncology.ru/association/clinical-guidelines/2014/32.pdf (In Russ.)].